Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Planned sale · Filed 09/01
Trade details
- Type
- Planned sale notice
- Planned sale date
- 26/09/01
- Filed
- 26/09/01
United Therapeutics Chair Martine A. Rothblatt files to sell $101.8M
Martine A. Rothblatt, Chairman of United Therapeutics UTHR, filed on 09/01 a notice to sell 199,500 shares, $101.8M in total, 0.5% of the shares outstanding, under a 10b5-1 plan adopted on 25/11/21. She sold 63 times in the past three months.
More to sell after $319M in 3 months
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 08/02~10/01Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1.1M
2,309 sh
$1.1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1M
2,135 sh
$1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$664.2K
1,395 sh
$664.2K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$574.9K
1,200 sh
$574.9K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$262.3K
552 sh
$262.3K
Filed 09/30
Traded 09/29